SCHEMBL322796

SCHEMBL322796

CC[C@H]1CNCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7097741 1.00
SCHEMBL12524834 1.00
SCHEMBL3168 1.00
Fluoride SCHEMBL7750151 1.00
Bromide SCHEMBL1608720 0.98
Hydrochloric Acid SCHEMBL3862781 0.98
Hydrochloric Acid SCHEMBL18528199 0.98
Ammonia Solution, Strong SCHEMBL331668 0.98
Water SCHEMBL7481154 0.98
SCHEMBL3663947 0.98

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119176847-A Steroid compound, application thereof, preparation method and pharmaceutical composition containing steroid compound 北京华睿鼎信科技有限公司 2024-12-24 CN disclosed
WO-2024141757-A1 LSD1 MODULATORS EXSCIENTIA AI LIMITED (GB) 2024-07-04 WO disclosed
WO-2024112512-A1 THIOL-CONTAINING ALCOHOLS FOR GENERATING NITRIC OXIDE AND METHODS OF FORMING THE SAME STERILE STATE LLC (US) 2024-05-30 WO disclosed
CN-117957226-A Heterocyclic compounds as SOS1 inhibitors and uses thereof 南京再明医药有限公司 2024-04-30 CN disclosed
US-20240025906-A1 KINASE MODULATORS AND METHODS OF USE THEREOF SUNDANCE BIOSCIENCES, INC. 2024-01-25 US disclosed
WO-2024010779-A1 ADDITIVES FOR POLYURETHANE FOAM POLYOL BLENDS AND POLYURETHANE FOAMS COMPRISING THE SAME MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2024-01-11 WO disclosed
US-11739100-B2 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof SANOFI (FR) 2023-08-29 US disclosed
US-11739100-B2 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof SANOFI (FR) 2023-08-29 US disclosed
US-20230203087-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2023-06-29 US disclosed
WO-2023122298-A1 PROTEIN STABILIZING COMPOUNDS CONTAINING USP28 AND/OR USP25 TARGETING LIGANDS Stablix, Inc. (US) 2023-06-29 WO disclosed
WO-2012123312-A1 PYRIDO[3,4-B]PYRAZINE DERIVATIVES AS SYK INHIBITORS GLAXO GROUP LIMITED (GB) 2012-09-20 WO disclosed
US-20120123114-A1 QUINAZOLINE DERIVATIVES HAVING TYROSINE KINASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2012-05-17 US disclosed
WO-2012004229-A1 RIGID POLYURETHANE FOAM BASF SE (DE) 2012-01-12 WO disclosed
US-20120009407-A1 RIGID POLYURETHANE FOAM BASF SE (DE) 2012-01-12 US disclosed
US-20110105506-A1 Diaminoalkane aspartic protease inhibitors VITAE PHARMACEUTICALS, INC. 2011-05-05 US disclosed
US-20090305998-A1 HSP90 INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-10 US disclosed
WO-2008154271-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-18 WO disclosed
US-20070191538-A1 An Article Formed From A Resin Composition Having A Polyurethane Encapsulated Particle BASF CORPORATION 2007-08-16 US disclosed
US-20070117955-A1 Coating composition BASF CORPORATION (US) 2007-05-24 US disclosed
US-6059990-A MIXTURE CONTAINS HIGH MOLECULAR WEIGHT COMPOUND BASF AKTIENGESELLSCHAFT (DE) 2000-05-09 US disclosed